news roundup
The collaboration combines ERT's EXPERT technology platform with Orbita Voice, a solution for creating conversational applications.
advertisment
Minimal Residual Disease Detection: Key Considerations for Clinical Development in Oncology
Live Webcast: Thursday, June 29 at 11:00am EDT Register now |
endpoint and Clinical Ink have teamed up to integrate IRT and eSource to create a seamless user experience for investigator sites.
advertisment
Coming to terms with Patient Centricity
Live Webinar: Tuesday, June 20 at 12:00pm EDT
Register now |
Under this partnership, CROS NT will offer its consumers Medidata's updated EDC platform, RaveX, as well as its RTSM system, Medidata Balance.
advertisment
Emerging Biopharma and Rare Disease: Finding a Needle in a Haystack
Data-driven Patient Recruitment Solutions
Live Webinar: Thursday, June 8 at 2:00pm EDT
Register now |
This article reports on industry trends from CBI's 3rd Annual Endpoint Adjudication Event, and will analyze the Endpoint Adjudication Survey results.
|
|
|
advertisment
Capturing Continuous Glucose Monitoring Advantages
Live Webinar: Wednesday, June 28 at 11:00am EDT Register now |
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
advertisment
Achieve Better Outcomes with New RBM Tech Enhancements
Live Webinar: Wednesday, June 7 at 11:00am EDT
Register now |
advertisment
Selecting and Auditing a Technology Vendor for Biopharmaceutical Development
Live Webcast: Thursday, June 8 at 11:00am EDT
Register now |
|
Blog Posts
Listen to DIA executives discuss current trends in drug development, and the best way to optimize your time at the annual meeting in Chicago.
advertisment
Talking the Patients' Language – the importance of effective, patient-centered engagement
Live Webinar: Tuesday, June 6 at 8:00am EDT
Register now |
Generics group in EU pushes its agenda as a cost solution after the European Commission issues country-by-country series of recommendations about getting public spending under control.
Some researchers use pragmatic randomized clinical trials (PCT), where treatment randomization is used to balance baseline characteristics and risk factors between treatment groups.
|
|
|
Articles
Atul Mahableshwarkar, Senior Medical Director at Takeda, offers his perspective on CNS drug development.
advertisment
Winning the RAT race: A new Center of Excellence to drive development of regenerative medicines
On Demand
Learn more |
This article from Ken Getz presents updated data characterizing protocol design and collaboration execution practices.
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|